Adequate adjustment from insulin degludec to insulin pump therapy in patient with type 1 diabetes

Adequate adjustment from insulin degludec to insulin pump therapy in patient with type 1 diabetes - From Degludec to insulin pump study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013136

Enrollment

Registered

2014-02-12

Start date

2014-02-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

Patients in Group 1 use degludec for 1 month. They start basal insulin infusion by insulin pump 24 hour after from last degludec injection. Patients in Group 2 use degludec for 1 month. They start ba

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 1 diabetes patients over 16 years old whose HbA1c is under 7.5%.

Exclusion criteria

Exclusion criteria: patient who is under15 years old. patient whose HbA1c is over 7.5% patient with severe diabetes complication.

Design outcomes

Primary

Measure	Time frame
AUC (area under the curve) for 8 hours from 24 hour after the last injection of insulin Degludec	—

Secondary

Measure	Time frame
mean blood glucose value, Standard Deviation (SD), HbA1c	—

Countries

Japan

Contacts

Public ContactMasakazu Hirose

Osaka City University Graduate School of Medicine Department of Pediatrics

hirose810@med.osaka-cu.ac.jp06-6645-3816

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026